Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy. - Wikidata - awgldk - TriplyDB

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.

http://www.wikidata.org/entity/Q33965263

about

Are there efficacious treatments for treating the fatigue-sleep disturbance-depression symptom cluster in breast cancer patients? A Rapid Evidence Assessment of the Literature (REAL(©))Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer.Cytokine gene associations with self-report ratings of morning and evening fatigue in oncology patients and their family caregivers.Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: a prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module Feasibility of implementing a community-based randomized trial of yoga for women undergoing chemotherapy for breast cancer.Dietary quercetin reduces chemotherapy-induced fatigue in mice.SNPs in PTGS2 and LTA predict pain and quality of life in long term lung cancer survivors.Prevalence and correlates of sleep disturbance in systemic sclerosis--results from the UCLA scleroderma quality of life study.Role of nuclear factor κB-mediated inflammatory pathways in cancer-related symptoms and their regulation by nutritional agents.Racial/ethnic disparities in inflammatory gene single-nucleotide polymorphisms as predictors of a high risk for symptom burden in patients with multiple myeloma 1 year after diagnosis.Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism?Caregivers of patients with cancer fatigue: a high level of symptom burden The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer.Longitudinal analysis of patient-reported symptoms post-autologous stem cell transplant and their relationship to inflammation in patients with multiple myeloma Randomised controlled trial on the effectiveness of home-based walking exercise on anxiety, depression and cancer-related symptoms in patients with lung cancer Palliative care in advanced cancer patients: how and when?The biology of cancer-related fatigue: a review of the literature.Biomarkers: symptoms, survivorship, and quality of life Associations between pro- and anti-inflammatory cytokine genes and breast pain in women prior to breast cancer surgery Vivekananda Yoga Program for Patients With Advanced Lung Cancer and Their Family Caregivers Interleukin-6 Prevents the Initiation but Enhances the Progression of Lung Cancer.Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy.Radiation, inflammation, and immune responses in cancer Changes in pain and other symptoms in patients with painful multiple myeloma-related vertebral fracture treated with kyphoplasty or vertebroplasty.Fatigue and sleep quality are associated with changes in inflammatory markers in breast cancer patients undergoing chemotherapy.Genetic predictors of fatigue in prostate cancer patients treated with androgen deprivation therapy: preliminary findings.Interventions to Alleviate Symptoms Related to Breast Cancer Treatments and Areas of Needed Research.Biological Basis for the Clustering of Symptoms.Sleep disturbance, inflammation and depression risk in cancer survivors Cancer-related fatigue--mechanisms, risk factors, and treatments.Sickness behavior induced by cisplatin chemotherapy and radiotherapy in a murine head and neck cancer model is associated with altered mitochondrial gene expression Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?Biopsychosocial predictors of pain among women recovering from surgery for endometrial cancer.Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancer Fatigue is associated with inflammation in patients with head and neck cancer before and after intensity-modulated radiation therapy.Prospective Study of Patient-Reported Symptom Burden in Patients With Non-Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy.Effects of 5-fluorouracil chemotherapy on fatigue: role of MCP-1.Dexamethasone for Dyspnea in Cancer Patients: A Pilot Double-Blind, Randomized, Controlled Trial.Inflammation at the intersection of behavior and somatic symptoms.

P2860

Q26785468-23979164-9DCD-4CCC-892D-438FAD62C9F5 Q33698419-1C553BBA-A037-42DE-B707-2B88E8D43D5F Q33727960-2FA0EF65-60C1-4C98-917A-E6C89C244F67 Q33839327-5EFC08FE-800E-4E39-A8E8-8D41C3C2FDA2 Q33893165-9749D856-5ABA-4CC9-A104-CC9FBF2234D1 Q33905142-0FFC4007-D0A4-4F2B-AE24-7A15D9219269 Q34060481-479420EF-2FA7-4DC7-87C4-03B1A24A8EB3 Q35038872-6BE68E51-A4C1-4820-A862-B54F9C8F6AF0 Q35048672-2EA26C25-D4AC-44C0-936C-010E67491C57 Q35120883-333272E5-AC9D-4A74-A2BE-5EDABBB85536 Q35202436-3383C55E-3BA6-4E81-8EB5-BD0A11F28B54 Q35229735-3935CC33-BEA3-455F-A181-6B53CE271D68 Q35358323-C067CA9C-DC43-4926-99D3-E1CDF74EBEC9 Q35446931-02F3AB0E-3C3B-40CD-BD08-3447FEE0B2ED Q35630256-576EE699-8937-4E09-8EC0-79DF21B11511 Q35677823-F7F9D9C4-E122-41C6-A165-A1BD89534F19 Q35776268-75CFD683-C423-41AE-83F0-081B11D36819 Q35793185-D4BFAC2A-1CC1-47B1-B6E9-5139968EB335 Q35923511-A797488E-8544-40C1-9ED1-0D61C0F1057A Q35946872-F331ACBE-5F87-405C-9103-CE4F121834D0 Q35958070-CD469562-6D3C-4E01-BA84-66E0AA9B98AF Q35958155-D1FD24C4-41B7-4CB5-8374-FF804263FC81 Q35968834-1D6C6C2F-1744-4D35-85F9-B56CCB16CA06 Q36005646-5F045B38-547E-4986-A8EC-98A246762D83 Q36007586-377926F3-8AD1-44CF-B649-1992F041336B Q36024587-1CF09E6D-294E-4193-85DF-145C08462C8D Q36101133-07D0421D-7BBF-46DE-A978-CD27BFC4904C Q36127633-3D721FF0-735A-40BD-AF99-BF7A7F3C8246 Q36173501-0BF327C4-F0CA-4D23-95EA-CC6174C8668A Q36213531-8CA7E0CA-7294-4ABB-AC73-E53707F12587 Q36332266-E5C609AC-1B35-45BE-9C8E-430B6E0FE558 Q36373009-CB9229DA-3685-472F-A9B7-89F9DEC77DDC Q36468050-D07BC5C3-E44B-445E-A2F6-628F95383129 Q36494713-E8D0F641-82C4-493F-8BD3-46C5C52425B8 Q36671163-EA305F4C-ACB9-4594-ABEB-F825F2C4006C Q36901888-3D878CD6-1C32-4AAF-9FF8-9B26A64E7CE4 Q36923727-A05C3BFB-34C7-435E-A78D-6D6926B6D8EA Q37012199-30A16423-799E-448E-A2AA-D47609826CB8 Q37120940-6FDABE40-A978-4968-A0CE-822240D8C3E3 Q37287493-A3A2D73C-877F-4144-AF8C-0B12C6E5B0FC

P2860

Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapy.

http://www.wikidata.org/entity/Q33965263

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@ast

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@en

type

label

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@ast

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@en

prefLabel

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@ast

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@en

P1433

Q33965263-6A94B2C0-AC19-46C6-A066-1EBC80D30E92

P1476

Q33965263-B855F8E5-FAAC-4BFF-BA47-C750D936FFA1

P2093

Q33965263-22139228-21ED-412A-8772-1B9FD373C920

Q33965263-4E5F89B5-12EE-4F79-8FE7-63F5561AF9D3

Q33965263-5C0A96D4-E17F-48E9-8385-CC537E0B6E2C

Q33965263-6710F1E3-C24E-4B49-AE3F-E4AF8FEC6D70

Q33965263-A14CF6CB-5EF1-41DB-B247-EB29A2448476

Q33965263-B3E4EBE7-7B22-434C-8846-4B7F7A2E3255

Q33965263-BFCDB37E-9F65-4F04-91DB-A4E0CF9178C2

Q33965263-F87DB1DE-2B75-43CF-9AD6-D02EC0E50FAB

P2860

Q33965263-1B9C544B-1BEC-4F3A-A72D-EA2E2A12D15E

Q33965263-1F54550C-D48D-4516-A029-2CC0FFD25926

Q33965263-27B48601-B375-478E-B8E3-22B6A526E336

Q33965263-2A004A27-7978-4609-9DF0-E3CFEC8E7F16

Q33965263-2EB69E4D-5E34-4C89-9972-D1364FCB5C0C

Q33965263-33C69B3C-CBE0-4F4D-BD88-2BE1EEC06DED

Q33965263-3C5C75EE-894A-4693-93DD-EF9690D00573

Q33965263-4071E2CC-FF15-40C8-9F37-6B5AAD97B394

Q33965263-57D5A1BD-E6F4-4C55-B6CF-A79869DF30FC

Q33965263-5B7DE328-496D-4A8B-9BA6-570B25440677

P304

Q33965263-BD1AB24B-CA46-469A-8EAB-79F021005CE5

P31

Q33965263-F2E93EFB-FCB1-4D56-8FE2-23916EE88E38

P356

Q33965263-3A9276EF-6E83-4146-8425-47118AE76BD0

P433

Q33965263-D9A2E5D7-A53E-4AE1-81EB-43991A30195B

P478

Q33965263-121CDC0C-3196-4C48-8861-CF0B9678E362

P577

Q33965263-5C0FACA6-6EAB-463E-875E-353A010C760B

P5875

Q33965263-DB0A4BCA-5B61-4C56-9104-5488D6C62526

P698

Q33965263-88787E5B-79D9-47D4-AE94-FF1FC1F004FF

P921

Q33965263-542FAC3B-B84C-4005-B2EC-68EEA1492F22

Q33965263-82E441B1-4F03-42CE-8A11-F9D9E6E3FB0B

Q33965263-8A347F9B-4868-4EA5-8FB8-7677FD36A6DB

P932

Q33965263-515B436F-12BB-42B7-921E-A42099957F00

P356

J.BBI.2010.03.009

P1433

Brain, Behavior, and Immunity

P1476

Inflammatory cytokines are ass ...... urrent chemoradiation therapy.

@en

P2093

Charles S Cleeland

http://www.w3.org/2001/XMLSchema#string

Gary M Mobley

http://www.w3.org/2001/XMLSchema#string

Li Mao

http://www.w3.org/2001/XMLSchema#string

Loretta A Williams

http://www.w3.org/2001/XMLSchema#string

Qiuling Shi

http://www.w3.org/2001/XMLSchema#string

Ritsuko R Komaki

http://www.w3.org/2001/XMLSchema#string

Xin Shelley Wang

http://www.w3.org/2001/XMLSchema#string

Zhongxing Liao

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2009

Cancer symptom assessment instruments: a systematic review.

Inflammatory biomarkers and fatigue during radiation therapy for breast and prostate cancer

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.

Cancer-related symptoms.

Cytokine-induced sickness behavior: where do we stand?

Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms.

Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.

A cytokine-based neuroimmunologic mechanism of cancer-related symptoms.

Symptom clusters in cancer patients: a review of the literature

P304

968-974

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBI.2010.03.009

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42767999

http://www.w3.org/2001/XMLSchema#string

P698

20353817

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

P932

2897921

http://www.w3.org/2001/XMLSchema#string